BeaconEquity.com’s Market News Issues ‘Cellcyte Genetics Corporation (CCYG) Expands its Research'
DALLAS – BeaconEquity.com announces the publication of ‘Cellcyte Genetics Corporation (CCYG) Expands its Research’
(EMAILWIRE.COM, February 23, 2008 ) DALLAS – BeaconEquity.com announces the publication of ‘Cellcyte Genetics Corporation (CCYG) Expands its Research’
Investors can view all of the investment articles for free by visiting:
http://www.BeaconEquity.com - Click on News and Commentary
Cellcyte Genetics Corporation (CCYG) Expands its Research
The biotechnology industry has expanded rapidly since 1992, with revenues increasing from $8 billion in 1992 to $50.7 billion in 2005. It is one of the most research-intensive industries in the world, with spending in 2005 of about $20 billion for research. The biosciences are a growing and vibrant sector of the US economy, with more than 40,000 business establishments being involved in activities ranging from agricultural and chemical production, to drug and pharmaceutical manufacturing, and research and testing activities in a laboratory setting.
Stem cells, an important subject of research in biotechnology industry, have demonstrated a solid potential for both scientific learning and novel therapeutics. Combined with novel approaches in bioengineering and molecular genetics, the possibilities for stem cells therapeutics are unlimited. However, the progress is slowed by the further hurdles of financial, ethical, cultural and political concerns. Thus, in 2006, the US Congress passed a bill to expand stem cell research. However, President Bush issued the first veto of his presidency. In 2007, Congress, now in Democratic hands, passed a similar bill by a larger margin, but still not by enough to override the veto that President Bush announced on June 20, 2007.
To read the entire article visit http://www.BeaconEquity.com – Click on News and Commentary
Join the fastest growing investor community at:
http://www.stockhideout.com
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.BeaconEquity.com
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.BeaconEquity.com
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
Investors can view all of the investment articles for free by visiting:
http://www.BeaconEquity.com - Click on News and Commentary
Cellcyte Genetics Corporation (CCYG) Expands its Research
The biotechnology industry has expanded rapidly since 1992, with revenues increasing from $8 billion in 1992 to $50.7 billion in 2005. It is one of the most research-intensive industries in the world, with spending in 2005 of about $20 billion for research. The biosciences are a growing and vibrant sector of the US economy, with more than 40,000 business establishments being involved in activities ranging from agricultural and chemical production, to drug and pharmaceutical manufacturing, and research and testing activities in a laboratory setting.
Stem cells, an important subject of research in biotechnology industry, have demonstrated a solid potential for both scientific learning and novel therapeutics. Combined with novel approaches in bioengineering and molecular genetics, the possibilities for stem cells therapeutics are unlimited. However, the progress is slowed by the further hurdles of financial, ethical, cultural and political concerns. Thus, in 2006, the US Congress passed a bill to expand stem cell research. However, President Bush issued the first veto of his presidency. In 2007, Congress, now in Democratic hands, passed a similar bill by a larger margin, but still not by enough to override the veto that President Bush announced on June 20, 2007.
To read the entire article visit http://www.BeaconEquity.com – Click on News and Commentary
Join the fastest growing investor community at:
http://www.stockhideout.com
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.BeaconEquity.com
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.BeaconEquity.com
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
Contact Information:
Beacon Equity Research
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Beacon Equity Research
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |




